BSX vs SWBI · P/E 20, rev $10.65B vs P/E 62, rev $523.8M
Boston Scientific Corp (BSX) versus Smith & Wesson Brands Inc (SWBI) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Smith & Wesson Brands Inc (SWBI) is a aerospace & defense company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported SWBI revenue for 2026-04-30 was $523.8M. Net income was $18.5M. Revenue was up 10.4% from 2025-04-30 to 2026-04-30. SWBI currently screens at market cap $659.4M and trailing P/E 61.8.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. SWBI currently screens at market cap $659.4M and trailing P/E 61.8.
Not investment advice. Open the BSX and SWBI stock pages for the full models.
Not investment advice.